spacer
home > ebr > summer 2018 > alternative approaches
PUBLICATIONS
European Biopharmaceutical Review

Alternative Approaches

Novel cancer therapies extend far beyond traditional chemo- and radiotherapy approaches. Specific small-molecule inhibitors or antibodies targeting epitopes at the surface of cancer cells are employed to fight cancer cells. Antibody-drug conjugates deliver toxic or radioactive compounds directly to the tumour cell, and bispecific antibodies present tumour cells to the immune system. Even more advanced immune therapies such as CAR-T techniques boost the immune system by modifying T-cells. Stem cell and gene editing-based therapies are getting off the starting blocks, raising hopes towards more effective and safer cancer therapies.

Despite their structural and molecular diversity, these novel therapies have one thing in common: unlike conventional therapies, which attack every fast-dividing cell, they aim to specifically target features unique to tumour cells, allowing the use of highly potent therapies while minimising side effects on healthy tissue. Therefore, identification and characterisation of target structures is a prerequisite to the success of novel cancer therapies.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Ute Boronowsky is a freelance science and marketing writer, translator, and journalist, covering topics relevant to the biotech and pharma industry. She received a PhD in biochemistry from the University of Bochum, Germany, did post-doctoral research in biochemistry at UCLA, US, and holds a degree in science journalism from the mibeg Institute for Media in Cologne, Germany. Ute has more than 15 years working experience from sales and marketing positions in the biotech industry and is co-founder of the start-up company Cube Biotech. She is member of the Chartered Institute of Linguists, UK, and of the Science Inbound writer’s network.
spacer
Dr Ute Boronowsky
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ACG to Showcase its Range of Capsules and Engineering Solutions at Supply Side West, Las Vegas

ACG, the only supplier in the world offering end-to-end manufacturing solutions for the pharmaceutical and the nutraceutical industries, will be exhibiting its wide range of Engineering and Capsules solutions at this year’s Supply Side West, Las Vegas. At ACG’s booth, the visitors will be able to see the synergies created with coupling ACG’s Capsules and Engineering products, thereby leveraging the many benefits of integrated manufacturing.
More info >>

White Papers

Environmental Factors in Data Centres

Dycem

In addition to temperature and humidity, there are many more constraints in the environment that increase failure rates, explains Emilio Sapińa of Secure Techincal Rooms.
More info >>

 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement